NCT05742100View on ClinicalTrials.gov

Darvadstrocel for Crohn's Fistula in the Realworld

CompletedOBSERVATIONAL
Enrollment

73

Participants

Timeline

Start Date

November 29, 2019

Primary Completion Date

April 21, 2022

Study Completion Date

April 21, 2022

Conditions
Crohn's Fistula
Interventions
DRUG

Darvadstrocel

expanded allogeneic adipose-derived mesenchymal stem cell therapy for the treatment of complex perianal fistulas

Trial Locations (1)

28040

Fundacion Jimenez Diaz, Madrid

All Listed Sponsors
lead

Dolores Herreros Marcos

OTHER

NCT05742100 - Darvadstrocel for Crohn's Fistula in the Realworld | Biotech Hunter | Biotech Hunter